ES460321A1 - Production of mutant of aujeszky's virus - Google Patents

Production of mutant of aujeszky's virus

Info

Publication number
ES460321A1
ES460321A1 ES460321A ES460321A ES460321A1 ES 460321 A1 ES460321 A1 ES 460321A1 ES 460321 A ES460321 A ES 460321A ES 460321 A ES460321 A ES 460321A ES 460321 A1 ES460321 A1 ES 460321A1
Authority
ES
Spain
Prior art keywords
mutant
virus
aujeszky
production
dedo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES460321A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmachim DSO
Original Assignee
Pharmachim DSO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmachim DSO filed Critical Pharmachim DSO
Publication of ES460321A1 publication Critical patent/ES460321A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16763—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Method for the preparation of the non-virulent viral mutant, aujeszky virus, characterized in that the nucleus of the virus containing deoxyribonucleic acid (dna) is acted on by antimetabolite 5.dedo-2-deoxyuridine, obtaining, after the eighth pass, a mutant non-pathogenic or immunogenic usable as a live vaccine. (Machine-translation by Google Translate, not legally binding)
ES460321A 1976-07-02 1977-07-01 Production of mutant of aujeszky's virus Expired ES460321A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BG3365276 1976-07-02

Publications (1)

Publication Number Publication Date
ES460321A1 true ES460321A1 (en) 1978-11-01

Family

ID=3902412

Family Applications (1)

Application Number Title Priority Date Filing Date
ES460321A Expired ES460321A1 (en) 1976-07-02 1977-07-01 Production of mutant of aujeszky's virus

Country Status (7)

Country Link
AR (1) AR216081A1 (en)
BE (1) BE856351A (en)
CA (1) CA1069821A (en)
ES (1) ES460321A1 (en)
FR (1) FR2356726A1 (en)
GB (1) GB1563284A (en)
NL (1) NL7707341A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3122669A1 (en) * 1980-06-12 1982-02-11 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld "METHOD FOR PRODUCING NEW MUTANTS OF HERPES SIMPLEX VIRUS TYPE 1 AND TYPE 2"
HU187421B (en) * 1982-10-27 1986-01-28 Phylaxia Oltoanyagtermeloe Vallalat,Hu Process for producing inactivated, adjuvated serum against aujeszky's illness
US4514497B1 (en) * 1983-12-30 1998-02-24 Novagene Inc Modified live pseudorabies viruses

Also Published As

Publication number Publication date
CA1069821A (en) 1980-01-15
FR2356726B1 (en) 1981-01-16
BE856351A (en) 1977-10-31
AR216081A1 (en) 1979-11-30
GB1563284A (en) 1980-03-26
FR2356726A1 (en) 1978-01-27
NL7707341A (en) 1978-01-04

Similar Documents

Publication Publication Date Title
JPS52102498A (en) Preparation of l-lysine
ES487046A1 (en) Purified bacterial proteoglycans, process for their preparation and vaccine containing them.
ATE38988T1 (en) IMIDAZOLYLPHENYL-TETRAHYDROPYRIDAZINE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
IE37602B1 (en) Cyclopentane derivatives
DE3060568D1 (en) Process for the preparation of 4,5-perfluoro-1,3-dioxolanes
ES460321A1 (en) Production of mutant of aujeszky's virus
IT7926898A0 (en) PROCEDURE FOR PREPARING 1,2,3-THIADIAZOL-5-IL-UREE.
JPS51146432A (en) Process for preparation of benzanilide derivatives having therapeutic action to immunological disease
ATE10498T1 (en) ALKYLAMINO-DESOXY1.4;3.6-DIANHYDRO-HEXITOL-NITRATES SUBSTITUTED BY PURINE BASES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATION.
FR2333805A1 (en) PROCESS FOR PREPARING N, N'-BIS-TRIMETHYLSILYLUREE
JPS5258335A (en) Program extending method by rom cassette system
DE3279264D1 (en) Method of immunizing pigs against aujeszky's disease
NO860508L (en) PROCEDURE FOR THE PREPARATION OF 4- (2-METOXYETHYL) -PHENYLGYLICIDYLETER AND / OR METOPROLOL.
JPS53143422A (en) Back mark detector
KR880001630A (en) 5-fluorouracil derivatives and uses thereof
ES485157A1 (en) Benzimidazolyl-2-carbamic acid esters, medicaments based thereon and process for their preparation.
JPS5334752A (en) Preparation of gamma-ionones and their derivatives
FR2310335A1 (en) PROCESS FOR PREPARING 3,5-DITERTIOBUTYL-4-HYDROXYBENZALDEHYDE FROM 3,5-DITERTIOBUTYL-4-HYDROXYBENZYL ALCOHOL
JPS5210492A (en) Preparation of xanthane gum
BE840837A (en) PROCESS FOR PREPARING PURE 1,8-DINITRO-ANTHRAQUINONE
JPS5212925A (en) A plant disease controlling agent
USD236248S (en) sntble
SU502900A1 (en) "Method for preparing α-alkyloxazazaphosphorinan derivatives-1,3,2
FR2334690A1 (en) PROCESS FOR PREPARING 3 ', 4'-DIDESOXYKANAMYCIN B
JPS5246023A (en) Process for preparation of organosulfinic acid salts